

MediHerb® GLP-1 Bitter Complex: Botanical Approach to Satiety Signaling
An Exclusive Evening of Healthcare Education, Dinner & Connection
Presented by the Global Healthcare Leaders Foundation
Join us for an engaging evening of education, meaningful conversation, and professional networking as we explore the evolving intersection of botanical science, metabolic wellness, and satiety signaling.
Featuring Julianna Murphy, Northeast District Sales Manager at Standard Process, this special presentation will introduce MediHerb® GLP-1 Bitter Complex and explore its botanical approach to satiety signaling.
What to Expect
Educational Presentation: Discover MediHerb's new GLP-1 Bitter Complex and the botanical concepts behind its approach to satiety signaling.
Practical Insights: Explore considerations for incorporating botanical wellness products into professional practice.
Dinner & Conversation: Enjoy an evening connecting with fellow healthcare practitioners and industry professionals.
Meaningful Connections: Build relationships with professionals committed to advancing healthcare education and innovation.
Featured Presenter Julianna Murphy Northeast District Sales Manager, Standard Process Julianna will share insights into MediHerb's GLP-1 Bitter Complex, its botanical approach, and practical considerations for healthcare practitioners.
Event Details Thursday, November 5, 2026 Time: 6:30 PM to 9:30 PM EST Location: Sen Sakana, 28 West 44th Street, New York, NY 10036 Hosted by: Global Healthcare Leaders Foundation Featured Organization: Standard Process / MediHerb
Who Should Attend? Physicians, healthcare practitioners, integrative and functional medicine professionals, wellness leaders, and healthcare industry professionals interested in botanical approaches to metabolic wellness.
Reserve your place and join us for an evening of education, dinner, and meaningful connections.
This event is intended for professional education and discussion. Product information should not be interpreted as evidence of clinical outcomes or equivalence to prescription GLP-1 medications.